• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与病因相关的掌腱膜挛缩症发病率和患病率的流行病学评估。

Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.

作者信息

Hindocha Sandip, McGrouther Duncan Angus, Bayat Ardeshir

机构信息

Plastic and Reconstructive Surgery Research, Manchester Interdisciplinary Biocenter, University of Manchester, 131 Princess St, Manchester M1 7DN, England, UK.

出版信息

Hand (N Y). 2009 Sep;4(3):256-69. doi: 10.1007/s11552-008-9160-9. Epub 2009 Jan 15.

DOI:10.1007/s11552-008-9160-9
PMID:19145463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2724613/
Abstract

Dupuytren's Disease (DD) is a common, fibroproliferative disorder affecting the palmar surface of the hands which is often irreversible and progressive. Understanding the epidemiology of DD is important in order to provide clues to its etiopathogenesis. This review aims to evaluate the epidemiological studies carried out in DD since 1951. Studies evaluating the epidemiology of DD were searched using Medline, Pubmed, and Scopus which dated back from 1951 to current date. Inclusion criteria were any studies investigating the prevalence or incidence of DD in any population group. A total of 620 articles were cited. Forty-nine studies were subsequently identified as relevant to evaluating the epidemiology of DD. The prevalence of DD in all studies increased with age with a male to female ratio of approximately 5.9:1. Prevalence rates ranged from 0.2% to 56% in varying age, population groups, and methods of data collection. The highest prevalence rate was reported in a study group of epileptic patients. Although, only one study calculated the incidence (as opposed to prevalence) of DD to be equal to 34.3 per 100,000 men (0.03%). In conclusion, the prevalence of DD in different geographical locations is extremely variable, and it is not clear whether this is genetic, environmental, or a combination of both. The majority of the prevalence studies have been conducted in Scandinavia or the UK, and the vast changes in population structure, the changes in prevalence of associated diseases, and the change in diagnostic criteria of DD makes understanding the epidemiology of this condition difficult.

摘要

掌腱膜挛缩症(DD)是一种常见的纤维增生性疾病,累及手掌表面,通常不可逆转且呈进行性发展。了解DD的流行病学对于揭示其病因发病机制很重要。本综述旨在评估自1951年以来开展的关于DD的流行病学研究。使用Medline、Pubmed和Scopus检索了1951年至今评估DD流行病学的研究。纳入标准为任何调查任何人群中DD患病率或发病率的研究。共引用了620篇文章。随后确定有49项研究与评估DD的流行病学相关。在所有研究中,DD的患病率随年龄增长而增加,男女比例约为5.9:1。在不同年龄、人群组和数据收集方法中,患病率范围为0.2%至56%。癫痫患者研究组报告的患病率最高。不过,只有一项研究计算出DD的发病率(与患病率相对)为每10万名男性中有34.3例(0.03%)。总之,DD在不同地理位置的患病率差异极大,目前尚不清楚这是由遗传、环境因素还是两者共同作用导致的。大多数患病率研究是在斯堪的纳维亚或英国进行的,而人口结构的巨大变化、相关疾病患病率的变化以及DD诊断标准的变化使得了解这种疾病的流行病学变得困难。

相似文献

1
Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology.与病因相关的掌腱膜挛缩症发病率和患病率的流行病学评估。
Hand (N Y). 2009 Sep;4(3):256-69. doi: 10.1007/s11552-008-9160-9. Epub 2009 Jan 15.
2
The Epidemiology of Dupuytren's Disease in Korea: a Nationwide Population-based Study.韩国的Dupuytren 氏病流行病学:一项全国性基于人群的研究。
J Korean Med Sci. 2018 Jun 18;33(31):e204. doi: 10.3346/jkms.2018.33.e204. eCollection 2018 Jul 30.
3
Epidemiology of Dupuytren's Disease in Japanese General Population.日本人普通人群中杜普伊特伦挛缩症的流行病学。
J Hand Surg Asian Pac Vol. 2021 Jun;26(2):229-234. doi: 10.1142/S2424835521500235.
4
The prevalence of Dupuytren's disease in patients with diabetes mellitus.糖尿病患者中掌腱膜挛缩症的患病率。
Commun Med (Lond). 2023 Jul 13;3(1):96. doi: 10.1038/s43856-023-00332-7.
5
What do we know about managing Dupuytren's disease cost-effectively?我们对如何经济有效地治疗掌腱膜挛缩症了解多少?
BMC Musculoskelet Disord. 2018 Jan 25;19(1):34. doi: 10.1186/s12891-018-1949-2.
6
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
7
Molecular phenotypic descriptors of Dupuytren's disease defined using informatics analysis of the transcriptome.使用转录组信息学分析定义的掌腱膜挛缩症的分子表型描述符。
J Hand Surg Am. 2008 Mar;33(3):359-72. doi: 10.1016/j.jhsa.2007.11.010.
8
The heritability of Dupuytren's disease: familial aggregation and its clinical significance.掌腱膜挛缩症的遗传度:家族聚集性及其临床意义。
J Hand Surg Am. 2006 Feb;31(2):204-10. doi: 10.1016/j.jhsa.2005.09.018.
9
The incidence and prevalence of Dupuytren's disease in primary care: results from a text mining approach on registration data.初级保健中掌腱膜挛缩症的发病率和患病率:基于登记数据文本挖掘方法的结果
Scand J Prim Health Care. 2025 Mar;43(1):173-180. doi: 10.1080/02813432.2024.2416678. Epub 2024 Oct 18.
10
Role of the HLA System in the Pathogenesis of Dupuytren's Disease.HLA系统在杜普伊特伦挛缩病发病机制中的作用。
Hand (N Y). 2010 Sep;5(3):241-50. doi: 10.1007/s11552-009-9255-y. Epub 2010 Feb 9.

引用本文的文献

1
Management of Dupuytren disease of the little finger.小指掌腱膜挛缩症的治疗
J Orthop Surg Res. 2025 Aug 22;20(1):789. doi: 10.1186/s13018-025-06176-2.
2
Associations of Demographic, Lifestyle, and Clinical Factors With the Presence of Dupuytren Disease: Results from the Lifelines Cohort Study.人口统计学、生活方式和临床因素与掌腱膜挛缩症的相关性:生命线队列研究结果
J Hand Surg Glob Online. 2025 Jul 24;7(5):100786. doi: 10.1016/j.jhsg.2025.100786. eCollection 2025 Sep.
3
Angiotensin Receptor Blockers Are Not Associated With Protective Benefits in Dupuytren's Disease.血管紧张素受体阻滞剂与掌腱膜挛缩症的保护益处无关。
Hand (N Y). 2025 Jun 12:15589447251343237. doi: 10.1177/15589447251343237.
4
Active synthesis of type I collagen homotrimer in Dupuytren's fibrosis is unaffected by anti-TNF-α treatment.在杜普伊特伦挛缩症纤维化中,I型胶原同三聚体的活性合成不受抗TNF-α治疗的影响。
JCI Insight. 2025 May 8;10(9). doi: 10.1172/jci.insight.175188.
5
Experience in the surgical treatment of Dupuytren's disease using WALANT anesthesia.采用腕部局部麻醉技术(WALANT)治疗掌腱膜挛缩症的手术经验。
J Hand Microsurg. 2025 Jan 30;17(3):100218. doi: 10.1016/j.jham.2025.100218. eCollection 2025 May.
6
The incidence and prevalence of Dupuytren's disease in primary care: results from a text mining approach on registration data.初级保健中掌腱膜挛缩症的发病率和患病率:基于登记数据文本挖掘方法的结果
Scand J Prim Health Care. 2025 Mar;43(1):173-180. doi: 10.1080/02813432.2024.2416678. Epub 2024 Oct 18.
7
Sex Difference in the Treatment of Dupuytren's Disease: A Systematic Review and Meta-Analysis of Clinical Trials.掌腱膜挛缩症治疗中的性别差异:临床试验的系统评价与荟萃分析
Plast Surg (Oakv). 2024 Aug;32(3):374-383. doi: 10.1177/22925503221141707. Epub 2022 Dec 4.
8
Pre-operative hand therapy management of Dupuytren's disease: A systematic review.Dupuytren病的术前手部治疗管理:一项系统评价。
Hand Ther. 2024 Jun;29(2):52-61. doi: 10.1177/17589983241227162. Epub 2024 Jan 28.
9
MMP-1, MMP-8, and MMP-13 Gene Polymorphisms and Haplotype Is a Risk Factor for Dupuytren Contracture: A Case-Control Study.基质金属蛋白酶-1、基质金属蛋白酶-8和基质金属蛋白酶-13基因多态性及单倍型是掌腱膜挛缩症的危险因素:一项病例对照研究。
Hand (N Y). 2024 Apr 25:15589447241242818. doi: 10.1177/15589447241242818.
10
Dupuytren Disease Surgical Treatment: A Randomized Clinical Trial Comparing Partial Fasciectomy by Bruner Approach Versus Zetaplasty.掌腱膜挛缩症的手术治疗: Bruner 入路部分筋膜切开术与 Zetaplasty 比较的随机临床试验。
Hand (N Y). 2024 Nov;19(8):1300-1307. doi: 10.1177/15589447231185581. Epub 2023 Jul 23.

本文引用的文献

1
Dupuytren's disease: personal factors and occupational exposure.掌腱膜挛缩症:个人因素与职业暴露
Am J Ind Med. 2008 Jan;51(1):9-15. doi: 10.1002/ajim.20542.
2
Dupuytren's disease following acute injury in Japanese patients: Dupuytren's disease or not?日本患者急性损伤后发生的掌腱膜挛缩症:是否为掌腱膜挛缩症?
J Hand Surg Eur Vol. 2007 Oct;32(5):569-72. doi: 10.1016/J.JHSE.2007.06.005. Epub 2007 Aug 2.
3
An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of Dupuytren's disease in 97,537 miners.对97537名矿工接触振动、吸烟、饮酒和患糖尿病情况对掌腱膜挛缩症患病率影响的评估。
J Hand Surg Eur Vol. 2007 Aug;32(4):400-6. doi: 10.1016/J.JHSE.2005.02.002. Epub 2007 May 25.
4
50 years experience with Dupuytren's contracture in the Erlangen University Hospital--a retrospective analysis of 2919 operated hands from 1956 to 2006.埃尔朗根大学医院50年掌腱膜挛缩症治疗经验——对1956年至2006年间2919例手术治疗手部病例的回顾性分析
BMC Musculoskelet Disord. 2007 Jul 4;8:60. doi: 10.1186/1471-2474-8-60.
5
Dupuytren's diathesis revisited: Evaluation of prognostic indicators for risk of disease recurrence.再探杜普伊特伦氏素质:疾病复发风险的预后指标评估
J Hand Surg Am. 2006 Dec;31(10):1626-34. doi: 10.1016/j.jhsa.2006.09.006.
6
The heritability of Dupuytren's disease: familial aggregation and its clinical significance.掌腱膜挛缩症的遗传度:家族聚集性及其临床意义。
J Hand Surg Am. 2006 Feb;31(2):204-10. doi: 10.1016/j.jhsa.2005.09.018.
7
Management of Dupuytren's disease--clear advice for an elusive condition.掌腱膜挛缩症的治疗——针对一种难以捉摸病症的明确建议。
Ann R Coll Surg Engl. 2006 Jan;88(1):3-8. doi: 10.1308/003588406X83104.
8
Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data.1950年至2002年英国肝硬化死亡率:常规数据分析
Lancet. 2006 Jan 7;367(9504):52-6. doi: 10.1016/S0140-6736(06)67924-5.
9
Can rock climbing lead to Dupuytren's disease?攀岩会导致掌腱膜挛缩症吗?
Br J Sports Med. 2005 Sep;39(9):639-44. doi: 10.1136/bjsm.2004.015792.
10
Dupuytren's disease in France--1831 to 2001--from description to economic burden.1831年至2001年法国的掌腱膜挛缩症——从描述到经济负担
J Hand Surg Br. 2005 Oct;30(5):484-7. doi: 10.1016/j.jhsb.2005.05.004.